NovaBay enters into exclusive distribution agreement with PBE NovaBay Pharmaceuticals announced that it has entered into an exclusive distribution agreement with Principle Business Enterprises. Under the agreement, PBE will market NovaBay's NeutroPhase Skin and Wound Cleanser in the U.S. for acute and chronic wounds. Under the agreement, PBE is responsible for marketing and commercialization of NeutroPhase in the U.S. NovaBay will assist in the training of PBE sales representatives and support PBE with key opinion leader development in the U.S..
NovaBay names Mark Sieczkarek as chairman, effective April 10 NovaBay Pharmaceuticals announces the appointment of Mark M. Sieczkarek as Chairman of the Board, effective April 10. NovaBay founder Dr. Ron Najafi remains on the Board and continues to serve as NovaBay’s President and CEO. Sieczkarek has served as a director of NovaBay since January 2014.